pharmaphorum October 29, 2025
Eli Lilly and tech giant NVIDIA have joined forces on an ambitious plan – building the most powerful AI-powered supercomputer to support drug discovery in the pharma industry.
Lilly said the supercomputer will power an ‘AI factory’ that will manage the entire AI lifecycle – from data acquisition and training to fine-tuning and high-volume inference – and enable AI-based research at a scale “previously thought impossible.”
Drug discovery using AI is being trumpeted as a way to shorten the time to lead candidate selection, reduce costs, and improve success rates, thanks to its ability to process large-scale datasets, uncover patterns, and generate predictions that can be deployed in the discovery of new targets and drug design.
The concept of AI-powered...
Today's Sponsors
Today's Sponsor